BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8709621)

  • 1. Angelmicin B, a new inhibitor of oncogenic signal transduction, inhibits growth and induces myelomonocytic differentiation of human myeloid leukemia HL-60 cells.
    Yokoyama A; Okabe-Kado J; Uehara Y; Oki T; Tomoyasu S; Tsuruoka N; Honma Y
    Leuk Res; 1996 Jun; 20(6):491-7. PubMed ID: 8709621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines.
    Asou H; Koike M; Elstner E; Cambell M; Le J; Uskokovic MR; Kamada N; Koeffler HP
    Blood; 1998 Oct; 92(7):2441-9. PubMed ID: 9746784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of novel uracil analogs on proliferation and differentiation of human myeloid leukemia cells.
    Makishima M; Honma Y; Hozumi M; Sampi K; Hattori M; Ishikawa I; Ogura H; Motoyoshi K
    Exp Hematol; 1992 Aug; 20(7):879-85. PubMed ID: 1321051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of activity of 1alpha, 25-dihydroxyvitamin D3 for growth inhibition and differentiation induction of human myelomonocytic leukemia cells by tretinoin tocoferil, an alpha-tocopherol ester of all-trans retinoic acid.
    Makishima M; Kanatani Y; Yamamoto-Yamaguchi Y; Honma Y
    Blood; 1996 Apr; 87(8):3384-94. PubMed ID: 8605356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs.
    Niitsu N; Umeda M; Honma Y
    Leuk Res; 2000 Jan; 24(1):1-9. PubMed ID: 10634639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethacrynic acid and 1 alpha,25-dihydroxyvitamin D3 cooperatively inhibit proliferation and induce differentiation of human myeloid leukemia cells.
    Makishima M; Honma Y
    Leuk Res; 1996 Sep; 20(9):781-9. PubMed ID: 8947589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of differentiation of human myeloid leukemia cells by novel synthetic neurotrophic pyrimidine derivatives.
    Honma Y; Ishii Y; Kasukabe T; Okabe-Kado J; Yamamoto-Yamaguchi Y; Kakegawa T; Awaya A
    Exp Hematol; 2001 Feb; 29(2):194-201. PubMed ID: 11166458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
    Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
    Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
    Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of inhibitors of protein tyrosine kinase activity and/or phosphatidylinositol turnover on differentiation of some human myelomonocytic leukemia cells.
    Makishima M; Honma Y; Hozumi M; Sampi K; Hattori M; Umezawa K; Motoyoshi K
    Leuk Res; 1991; 15(8):701-8. PubMed ID: 1895751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
    Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
    Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differanisole A, a novel antitumor antibiotic, enhances growth inhibition and differentiation of human myeloid leukemia cells induced by 9-cis retinoic acid.
    Kanatani Y; Makishima M; Asahi K; Sakurai A; Takahashi N; Motoyoshi K; Nagata N; Honma Y
    Biochim Biophys Acta; 1997 Oct; 1359(1):71-9. PubMed ID: 9398087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25-Dihydroxyvitamin D3 promotes prostaglandin E1-induced differentiation of HL-60 cells.
    Kawase T; Ogata S; Orikasa M; Burns DM
    Calcif Tissue Int; 1995 Nov; 57(5):359-66. PubMed ID: 8564798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of differentiation of human myeloid leukemia HL-60 cells by novel pyrimidine nucleoside analogs.
    Makishima M; Honma Y; Hozumi M; Sampi K; Hattori M; Ishikawa I; Ogura H; Kawahara N; Kanaiwa T; Motoyoshi K
    Biochim Biophys Acta; 1991 Aug; 1094(1):1-7. PubMed ID: 1883847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of differentiation of human myeloid leukemia cells by jasmonates, plant hormones.
    Ishii Y; Kiyota H; Sakai S; Honma Y
    Leukemia; 2004 Aug; 18(8):1413-9. PubMed ID: 15229618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
    Yamamoto-Yamaguchi Y; Makishima M; Kanatani Y; Kasukabe T; Honma Y
    Exp Hematol; 1996 May; 24(6):682-9. PubMed ID: 8635523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel uracil analog, 6-chloro-5-(2-propenyl)uracil, preferentially enhances growth inhibition and differentiation of myeloid leukemia cells induced by 1alpha,25-dihydroxyvitamin D3.
    Kanatani Y; Makishima M; Ishikawa I; Ogasawara Y; Kawahara N; Motoyoshi K; Nagata N; Honma Y
    Exp Hematol; 1998 Mar; 26(3):198-206. PubMed ID: 9502615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells.
    Makishima M; Shudo K; Honma Y
    Biochem Pharmacol; 1999 Mar; 57(5):521-9. PubMed ID: 9952315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.